Skip to main content

Find Clinical Trials

Home
Conditions
Immunoproliferative Disorders

Clinical trial condition

Immunoproliferative Disorders

Explore clinical trials studying Immunoproliferative Disorders. Study availability and eligibility vary by location and protocol.

9,977 public trials 2,028 recruiting studies

Refine in advanced search Browse all conditions

Immunoproliferative Disorders trial results

Completed

Entinostat and Clofarabine in Treating Patients With Newly Diagnosed, Relapsed, or Refractory Poor-Risk Acute Lymphoblastic Leukemia or Bilineage/Biphenotypic Leukemia

NCT01132573

Conditions: Acute Leukemias of Ambiguous Lineage, Hematologic Diseases, Hemic and Lymphatic Diseases, +13 more
Locations: University of Colorado Anschutz Medical Campus Aurora, Colorado, United States

University of Colorado Denver, Colorado, United States

University of Maryland/Greenebaum Cancer Center Baltimore, Maryland, United States

Johns Hopkins University/Sidney Kimmel Comprehensive Cancer Center Baltimore, Maryland, United States

View Trial Details

Completed

Study to Evaluate the Safety and Efficacy of Adeno-IFN Gamma in Cutaneous B-cell Lymphoma

NCT00394693

Conditions: Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +11 more
Locations: Stanford University School of Medicine Stanford, California, United States

Northwestern University Medical School Chicago, Illinois, United States

M.D. Anderson Cancer Center Houston, Texas, United States

Hopital Lapeyronie Montpellier, France

View Trial Details

Completed

Pharmacogenetic Analysis of Korean Pediatric Patients With Acute Lymphoblastic Leukemia

NCT01556386

Conditions: Acute Lymphoblastic Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +9 more
Locations: Seoul National University Hospital Seoul, Chongno-gu, South Korea

View Trial Details

Completed

Study of GTx-024 on Muscle Wasting (Cachexia) Cancer.

NCT00467844

Conditions: Atrophy, Body Weight, Body Weight Changes, +37 more
Locations: Alaska Cancer Research and Education Center Anchorage, Alaska, United States

Highlands Oncology Group Fayetteville, Arkansas, United States

Compassionate Cancer Care Corona, California, United States

Compassionate Cancer Care Medical Group Fountain Valley, California, United States

View all 52 locations

View Trial Details

Completed

Ofatumumab (Humax-CD20) With CHOP (Cyclophosphamide,Doxorubicin, Vincristine, Predisolone) in Follicular Lymphoma (FL) Patients

NCT00494780

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
Locations: GSK Investigational Site Buffalo, New York, United States

View Trial Details

Completed

Tamoxifen in the Prevention of Breast Cancer in Hodgkin's Disease Survivors

NCT00165308

Conditions: Breast Cancer, Breast Diseases, Breast Neoplasms, +13 more
Locations: Massachusetts General Hospital Boston, Massachusetts, United States

Dana-Farber Cancer Institute Boston, Massachusetts, United States

View Trial Details

Completed

Wilm's Tumor 1 (WT1) Peptide Vaccine for High Risk Hematologic Malignancy

NCT00433745

Conditions: Acute Myeloid Leukemia (AML), Bone Marrow Diseases, Chronic Disease, +21 more
Locations: National Cancer Institute (NCI), 9000 Rockville Pike Bethesda, Maryland, United States

View Trial Details

Completed

High Dose Sequential Therapy and Autologous Stem Cell Rescue for Multiple Myeloma

NCT00586014

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: Not specified

View Trial Details

Completed

Phase IV Observational Study in Chronic Lymphocytic Leukemia

NCT01453062

Conditions: Chronic Disease, Disease Attributes, Hematologic Diseases, +14 more
Locations: Not specified

View Trial Details

Completed

Open-label Extension Study of Navitoclax in Subjects With Chronic Lymphocytic Leukemia (CLL)

NCT01557777

Conditions: Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +14 more
Locations: Site Reference ID/Investigator# 74036 La Jolla, California, United States

Site Reference ID/Investigator# 74035 Los Angeles, California, United States

Site Reference ID/Investigator# 74038 Pleasant Hill, California, United States

Site Reference ID/Investigator# 74039 Santa Maria, California, United States

View all 15 locations

View Trial Details